UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 469

Sortiert nach

Antioxidant response elements: Discovery, classes, regulation and potential applications

Redox biology, 2018-07, Vol.17, p.297-314

2018

Volltextzugriff (PDF)

Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer

Current vascular pharmacology, 2017-01, Vol.15 (6), p.503

2017

Volltextzugriff (PDF)

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

Molecular cancer, 2023-08, Vol.22 (1), p.1-138, Article 138

2023

Volltextzugriff (PDF)

Triple negative breast cancer in Asia: An insider’s view

Cancer treatment reviews, 2018-01, Vol.62, p.29-38

2018

Volltextzugriff (PDF)

Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairment

Scientific reports, 2021-02, Vol.11 (1), p.4010-4010, Article 4010

2021

Volltextzugriff (PDF)

Antibacterial and Cellular Behaviors of Novel Zinc-Doped Hydroxyapatite/Graphene Nanocomposite for Bone Tissue Engineering

International journal of molecular sciences, 2021-09, Vol.22 (17), p.9564

2021

Volltextzugriff (PDF)

Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma

Frontiers in pharmacology, 2018-05, Vol.9, p.365-365

2018

Volltextzugriff (PDF)

Magneto‐Fluorescent Perovskite Nanocomposites for Directed Cell Motion and Imaging

Advanced healthcare materials, 2019-12, Vol.8 (23), p.e1900859-n/a

2019

Volltextzugriff (PDF)

Possible use of Punica granatum (Pomegranate) in cancer therapy

Pharmacological research, 2018-07, Vol.133, p.53-64

2018

Volltextzugriff (PDF)

Ginkgolic Acids Confer Potential Anticancer Effects by Targeting Pro- Inflammatory and Oncogenic Signaling Molecules

Current molecular pharmacology, 2021-01, Vol.14 (5), p.806

2021

Volltextzugriff (PDF)

Therapeutic potential of gambogic acid, a caged xanthone, to target cancer

Cancer letters, 2018-03, Vol.416, p.75-86

2018

Volltextzugriff (PDF)

Tocotrienols: the unsaturated sidekick shifting new paradigms in vitamin E therapeutics

Drug discovery today, 2017-12, Vol.22 (12), p.1765-1781

2017

Volltextzugriff (PDF)

Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4

Frontiers in pharmacology, 2017-03, Vol.8, p.124-124

2017

Volltextzugriff (PDF)

Fangchinoline targets epithelial–mesenchymal transition process by modulating activation of multiple cell‐signaling pathways

Journal of cellular biochemistry, 2022-07, Vol.123 (7), p.1222-1236

2022

Volltextzugriff (PDF)

‘Lnc’‐ing Wnt in female reproductive cancers: therapeutic potential of long non‐coding RNAs in Wnt signalling

British journal of pharmacology, 2017-12, Vol.174 (24), p.4684-4700

2017

Volltextzugriff (PDF)

Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity

Journal of cellular physiology, 2022-05, Vol.237 (5), p.2309-2344

2022

Volltextzugriff (PDF)

Double-edged Swords: Diaryl pyrazoline thiazolidinediones synchronously targeting cancer epigenetics and angiogenesis

Bioorganic chemistry, 2021-11, Vol.116, p.105350-105350, Article 105350

2021

Volltextzugriff (PDF)

microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer

Biological reviews of the Cambridge Philosophical Society, 2016-05, Vol.91 (2), p.409-428

2016

Volltextzugriff (PDF)

Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarks

RSC medicinal chemistry, 2021-09, Vol.12 (9), p.154-1554

2021

Volltextzugriff (PDF)

PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple Negative Breast Cancers

Molecular cancer therapeutics, 2017-11, Vol.16 (11), p.2528-2542

2017

Volltextzugriff (PDF)

PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers

Molecular cancer therapeutics, 2017-11, Vol.16 (11), p.2528

2017

Volltextzugriff (PDF)

Development and investigation of thiazolidinedione and pyrazoline compounds as antiangiogenic weapons targeting VEGFR-2

Future medicinal chemistry, 2021-11, Vol.13 (22), p.1963-1986

2021

Volltextzugriff (PDF)

Inducible nitric oxide synthase expression is inhibited by myeloperoxidase

Nitric oxide, 2005-08, Vol.13 (1), p.42-53

2005

Volltextzugriff (PDF)

A novel small-molecule inhibitor of trefoil factor 3 (TFF3) potentiates MEK1/2 inhibition in lung adenocarcinoma

Oncogenesis (New York, NY), 2019-11, Vol.8 (11), p.65-16, Article 65

2019

Volltextzugriff (PDF)

Statins downregulate myeloperoxidase gene expression in macrophages

Biochemical and biophysical research communications, 2005-06, Vol.331 (2), p.442-451

2005

Volltextzugriff (PDF)

1 – 25 von 469

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(418)
Mit Volltextzugriff
(402)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(329)
Life Sciences & Biomedicine
(236)
Humans
(189)
Female
(96)
Male
(91)
Physical Sciences
(71)
Middle Aged
(66)
Aged
(51)
Animals
(49)
Biological And Medical Sciences
(46)
Chemistry
(45)
Adult
(44)
Biochemistry & Molecular Biology
(41)
Technology
(41)
Medical Sciences
(40)
Cancer
(35)
Science & Technology - Other Topics
(33)
Oncology
(30)
Tumors
(30)
Mutation
(29)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Antioxidant response elements: Discovery, classes, regulation and potential applications

Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

Triple negative breast cancer in Asia: An insider’s view

Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairment

Antibacterial and Cellular Behaviors of Novel Zinc-Doped Hydroxyapatite/Graphene Nanocomposite for Bone Tissue Engineering

Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma

Magneto‐Fluorescent Perovskite Nanocomposites for Directed Cell Motion and Imaging

Possible use of Punica granatum (Pomegranate) in cancer therapy

Ginkgolic Acids Confer Potential Anticancer Effects by Targeting Pro- Inflammatory and Oncogenic Signaling Molecules

Therapeutic potential of gambogic acid, a caged xanthone, to target cancer

Tocotrienols: the unsaturated sidekick shifting new paradigms in vitamin E therapeutics

Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4

Fangchinoline targets epithelial–mesenchymal transition process by modulating activation of multiple cell‐signaling pathways

‘Lnc’‐ing Wnt in female reproductive cancers: therapeutic potential of long non‐coding RNAs in Wnt signalling

Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity

Double-edged Swords: Diaryl pyrazoline thiazolidinediones synchronously targeting cancer epigenetics and angiogenesis

microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer

Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarks

PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple Negative Breast Cancers

PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers

Development and investigation of thiazolidinedione and pyrazoline compounds as antiangiogenic weapons targeting VEGFR-2

Inducible nitric oxide synthase expression is inhibited by myeloperoxidase

A novel small-molecule inhibitor of trefoil factor 3 (TFF3) potentiates MEK1/2 inhibition in lung adenocarcinoma

Statins downregulate myeloperoxidase gene expression in macrophages

Suchergebnisse filtern